Cardiomems

Abbott.com · United States of America

CardioMEMS is a medical device technology acquired by Abbott that provides an implantable pulmonary artery pressure monitoring system used to manage patients with heart failure. The system wirelessly transmits pressure data from a small sensor implanted in the pulmonary artery to clinicians, enabling earlier intervention and optimization of therapy. Abbott commercializes CardioMEMS through hospitals and cardiology practices as part of its cardiovascular medical devices portfolio.

Revenue
$43.0B
Employees
115,000
Founded
1888
Headquarters
United States of America

What 8 Arbolus experts think of Cardiomems

NPS scores range widely, from 3 (detractor) to 10 (promoter), with concentrations in the 8-10 range among high spenders and Influencers, and lower NPS among low spenders. High renewal intent aligns with high NPS and spend: both $2M+ accounts indicated continued use with NPS 10. Stickiness data shows 78% have implemented the product more than one year, reflecting strong embeddedness. Sentiment is polarized at the low spend/short tenure end, but predominantly positive among enterprise users.Overall Customer Sentiment: Positive

Who reviewed Cardiomems

Total customers 8 7 current · 1 former
Reviews growth +7 in six months
Seniority of respondents
  • C-Suite 71% (6)
  • Director 29% (2)
Other Analyst C-Suite NPS 9
Operations Leader Director NPS 10 Will renew
Not specified C-Suite NPS 8

Employer names and spend open once the report publishes.

Tell us when the Cardiomems report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

0 Net Promoter Score, from 8 scored reviews
  • Promoters 3
  • Passives 2
  • Detractors 3

Cumulative NPS by month

-2 over 5 months
  • Sep 10
  • Apr 8
  • May 8
  • Jun 8
  • Jul 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 0 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 67%
  • Will renew 2
  • Undecided 0
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 1 answer
  • Director 100% 2 answers
  • 10/10 Average score from customers who will renew
  • 5/10 Average score from customers not renewing

For people who use Cardiomems

Do you use Cardiomems at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 8 customers of Cardiomems have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.